Tsutomu Tamada1, HIroki Higashi1, Teruki Sone1, Yoshimasa Jo2, Atsushi Higaki1, Akihiko Kanki1, Akira Yamamoto1, Katsuyoshi Ito1
1Radiology, Kawasaki Medical School, Kurashiki City, Okayama, Japan; 2Urology, Kawasaki Medical School, Kurashiki City, Okayama, Japan
We evaluated the utility of T2WI, DCE-MRI and DWI for detecting prostate cancer with total serum PSA levels of 4-10 ng/ml (gray zone). Combined T2WI, DWI, and DCE-MRI findings would be potentially useful for detecting and managing prostate cancer, even if performed for patients with gray-zone PSA levels.